Veronica Galvan Hart

  • 3656 Citations
  • 32 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Veronica Galvan Hart is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles
Alzheimer Disease Medicine & Life Sciences
Amyloid beta-Protein Precursor Medicine & Life Sciences
Sirolimus Medicine & Life Sciences
Amyloid Medicine & Life Sciences
Transgenic Mice Medicine & Life Sciences
Brain Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Caspases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2019

  • 3656 Citations
  • 32 h-Index
  • 63 Article
  • 1 Editorial
  • 1 Review article

mTOR in cerebrovascular disease

Van Skike, C. E. & Galvan Hart, V., Mar 15 2019, In : Aging. 11, 5, p. 1331-1332 2 p.

Research output: Contribution to journalEditorial

Cerebrovascular Disorders
Blood-Brain Barrier
Alzheimer Disease
7 Citations (Scopus)

Obesity in Aging Exacerbates Neuroinflammation, Dysregulating Synaptic Function-Related Genes and Altering Eicosanoid Synthesis in the Mouse Hippocampus: Potential Role in Impaired Synaptic Plasticity and Cognitive Decline

Valcarcel-Ares, M. N., Tucsek, Z., Kiss, T., Giles, C. B., Tarantini, S., Yabluchanskiy, A., Balasubramanian, P., Gautam, T., Galvan Hart, V., Ballabh, P., Richardson, A., Freeman, W. M., Wren, J. D., Deak, F., Ungvari, Z. & Csiszar, A., Feb 15 2019, In : The journals of gerontology. Series A, Biological sciences and medical sciences. 74, 3, p. 290-298 9 p.

Research output: Contribution to journalArticle

Open Access
Neuronal Plasticity
Long-Term Potentiation
4 Citations (Scopus)

Rapamycin and Alzheimer's disease: Time for a clinical trial?

Kaeberlein, M. & Galvan Hart, V., Jan 23 2019, In : Science Translational Medicine. 11, 476, eaar4289.

Research output: Contribution to journalReview article

Alzheimer Disease
Clinical Trials
Animal Models
Pharmaceutical Preparations
8 Citations (Scopus)

A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review

Van Skike, C. E. & Galvan Hart, V., Jan 11 2018, (Accepted/In press) In : Gerontology.

Research output: Contribution to journalArticle

Alzheimer Disease
Blood Vessels
Cerebrovascular Circulation
11 Citations (Scopus)

Hydrogen sulfide ameliorates aging-associated changes in the kidney

Lee, H. J., Feliers, D., Barnes, J. L., Oh, S., Ghosh-choudhury, G., Diaz, V., Galvan Hart, V., Strong, J. R., Nelson, J. F., Salmon, A., Kevil, C. G. & Kasinath, B. S., May 1 2018, (Accepted/In press) In : GeroScience. p. 1-14 14 p.

Research output: Contribution to journalArticle

Hydrogen Sulfide
AMP-Activated Protein Kinases